+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Kyphoplasty Market Size, Share & Industry Trends Analysis Report By Product Type (Accessories and Kyphoplasty Systems), By Indication (Osteoporosis and Others), By End User, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 81 Pages
  • July 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5645552
The Latin America, Middle East and Africa Kyphoplasty Market is expected to witness market growth of 9.5% CAGR during the forecast period (2022-2028).

There is no difference in the postoperative complication rates between kyphoplasty and vertebroplasty, and the complication rate following kyphoplasty is modest. Also, there is no distinction between the 2 approaches in terms of new fracture rates or nearby fracture rates. Although cement embolism is uncommon, it has been observed. Asymptomatic cement extravasations are common. Overall, kyphoplasty appears to be more effective than conservative care in the treatment of painful VCFs.

Vertebroplasty and kyphoplasty carry extremely little risk. There is a tiny possibility that patients could develop an infection, bleeding, worsened back pain, or tingling and numbness. There is a chance that extra vertebral bodies in the spine could fracture if someone has osteoporosis. The doctor will want to make sure that patients are taking medications to enhance the quality of the bones in order to reduce this risk.

The patient will receive detailed post-operative instructions from the doctor, but in general, they will stay in the recovery area for around an hour. A nurse attentively keeps track of the vital signs, including any back pain. After their balloon kyphoplasty treatment, the majority of patients are released from the hospital or ASC within 24 hours. The surgeon will examine patients after surgery to monitor the healing and determine whether the patient should limit certain activities (e.g., lifting). Patients might not need to alter their level of physical activity because many patients report considerable improvements in their pain, mobility, and capacity to carry out everyday duties.

UAE is a federation of seven emirates with a high percentage of foreign workers and a modern road infrastructure. Health and safety are particularly hampered by the diversity of social, religious, and educational practices among various ethnic groups. Conducting appropriate epidemiological investigations is required in order to suggest effective preventive actions. The authorities sought to evaluate the mechanism of injury, severity, and outcome of hospitalized spinal injured patients in the UAE. 
The Brazil market dominated the LAMEA Kyphoplasty Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $13.7 million by 2028. The Argentina market is experiencing a CAGR of 10.1% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 9.2% during (2022 - 2028).

Based on Product Type, the market is segmented into Accessories and Kyphoplasty Systems. Based on Indication, the market is segmented into Osteoporosis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, MicroPort Scientific Corporation, IZI Medical Products, LLC (Landauer, Inc.), Merit Medical Systems, Inc., Jiangsu Changmei Medtech Co. Ltd., G21 S.r.l., Seawon Meditech Co., Ltd., joimax® GmbH and Taeyeon medical Co., Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Product Type

  • Accessories
  • Kyphoplasty Systems

By Indication

  • Osteoporosis
  • Others

By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Medtronic PLC
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • IZI Medical Products, LLC (Landauer, Inc.)
  • Merit Medical Systems, Inc.
  • Jiangsu Changmei Medtech Co. Ltd.
  • G21 S.r.l.
  • Seawon Meditech Co., Ltd.
  • joimax® GmbH
  • Taeyeon medical Co., Ltd.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Kyphoplasty Market, by Product Type
1.4.2 LAMEA Kyphoplasty Market, by Indication
1.4.3 LAMEA Kyphoplasty Market, by End User
1.4.4 LAMEA Kyphoplasty Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. LAMEA Kyphoplasty Market by Product Type
4.1 LAMEA Accessories Market by Country
4.2 LAMEA Kyphoplasty Systems Market by Country
Chapter 5. LAMEA Kyphoplasty Market by Indication
5.1 LAMEA Osteoporosis Market by Country
5.2 LAMEA Others Market by Country
Chapter 6. LAMEA Kyphoplasty Market by End User
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Ambulatory Surgical Centers Market by Country
Chapter 7. LAMEA Kyphoplasty Market by Country
7.1 Brazil Kyphoplasty Market
7.1.1 Brazil Kyphoplasty Market by Product Type
7.1.2 Brazil Kyphoplasty Market by Indication
7.1.3 Brazil Kyphoplasty Market by End User
7.2 Argentina Kyphoplasty Market
7.2.1 Argentina Kyphoplasty Market by Product Type
7.2.2 Argentina Kyphoplasty Market by Indication
7.2.3 Argentina Kyphoplasty Market by End User
7.3 UAE Kyphoplasty Market
7.3.1 UAE Kyphoplasty Market by Product Type
7.3.2 UAE Kyphoplasty Market by Indication
7.3.3 UAE Kyphoplasty Market by End User
7.4 Saudi Arabia Kyphoplasty Market
7.4.1 Saudi Arabia Kyphoplasty Market by Product Type
7.4.2 Saudi Arabia Kyphoplasty Market by Indication
7.4.3 Saudi Arabia Kyphoplasty Market by End User
7.5 South Africa Kyphoplasty Market
7.5.1 South Africa Kyphoplasty Market by Product Type
7.5.2 South Africa Kyphoplasty Market by Indication
7.5.3 South Africa Kyphoplasty Market by End User
7.6 Nigeria Kyphoplasty Market
7.6.1 Nigeria Kyphoplasty Market by Product Type
7.6.2 Nigeria Kyphoplasty Market by Indication
7.6.3 Nigeria Kyphoplasty Market by End User
7.7 Rest of LAMEA Kyphoplasty Market
7.7.1 Rest of LAMEA Kyphoplasty Market by Product Type
7.7.2 Rest of LAMEA Kyphoplasty Market by Indication
7.7.3 Rest of LAMEA Kyphoplasty Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Partnerships, Collaborations and Agreements:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Stryker Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Geographical Expansions:
8.2.5.2 Approvals and Trials:
8.3 MicroPort Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 IZI Medical Products, LLC (Landauer, Inc.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Product Launches and Product Expansions:
8.4.2.2 Acquisition and Mergers:
8.5 Merit Medical Systems, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Jiangsu Changmei Medtech Co., Ltd.
8.6.1 Company Overview
8.7 G21 S.r.l.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Approvals and Trials:
8.8 Seawon Meditech Co., Ltd.
8.8.1 Company Overview
8.9 joimax® GmbH
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.10. Taeyeon Medical Co., Ltd.
8.10.1 Company Overview

Companies Mentioned

  • Medtronic PLC
  • Stryker Corporation
  • MicroPort Scientific Corporation
  • IZI Medical Products, LLC (Landauer, Inc.)
  • Merit Medical Systems, Inc.
  • Jiangsu Changmei Medtech Co. Ltd.
  • G21 S.r.l.
  • Seawon Meditech Co., Ltd.
  • joimax® GmbH
  • Taeyeon medical Co., Ltd.

Methodology

Loading
LOADING...